EUVIMEDEUVIMED entdecken
Crossref

Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood–brain barrier integrity following rtPA reperfusion after MCAO in mice

Yangmin Zheng, Shubei Ma, Wei Sun, Feng Yan, Yumin Luo

Inflammopharmacology · 2025

DOI: 10.1007/s10787-025-01757-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Yangmin Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cyclosporine, Inflammation, Tissue Plasminogen Activator. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Dalian Municipal Health Commission's Peak Climbing Plan Project, Dalian Municipal Health Commission’s Peak Climbing Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemorrhagic transformation (HT) is the most serious complication after rtPA thrombolytic therapy in patients with acute ischemic stroke, which greatly limits the clinical application of rtPA. rtPA disruption of the blood-brain barrier (BBB) by inducing inflammation after cerebral ischemia may be an important mechanism for the development of HT, and maintaining BBB integrity can significantly reduce the risk of HT. Our study found that a new generation of calcineurin inhibitors, voclosporin can improve neurological function, reduce neuronal damage, and reduce cerebral infarction volume in mice. By Evans blue extravasation assay and cerebral water content measurement, it was found that voclosporin could improve BBB injury and reduce brain edema caused by rt-PA. The ELISA and immunofluorescence experiments further proved that voclosporin can reduce the expression of IL-1β/TNF-α, increase the expression of IL-10/IL-4, and protect the integrity of the BBB by promoting microglia/macrophage to M2 type polarization, providing new thinking for clinical rtPA combined therapy to alleviate BBB damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierCyclosporineInflammationTissue Plasminogen ActivatorInfarction, Middle Cerebral ArteryAnimalsMiceMaleMice, Inbred C57BLRecovery of FunctionReperfusion InjuryDisease Models, AnimalBrain Edema

Stichwörter der Autor:innen

Blood–brain barrierIschemic strokeVoclosporinrtPA

Substanzen

CyclosporineTissue Plasminogen Activator

Autor:innen und Institutionen

  • Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
  • Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China.
  • Department of Neurology, Central Hospital of Dalian University of Technology, Dalian, 116000, China. mshb1980@vip.163.com.
  • Department of Neurology, Dalian No. 3 People's Hospital, Dalian, China.

Förderung

  • Dalian Municipal Health Commission's Peak Climbing Plan Project
  • Dalian Municipal Health Commission’s Peak Climbing Plan Project

Zitieren

APA

Zheng, Y., Ma, S., Sun, W., Yan, F., & Luo, Y. (2025). Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood–brain barrier integrity following rtPA reperfusion after MCAO in mice. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01757-3

Vancouver

Zheng Y, Ma S, Sun W, Yan F, Luo Y. Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood–brain barrier integrity following rtPA reperfusion after MCAO in mice. Inflammopharmacology. 2025. doi:10.1007/s10787-025-01757-3

BibTeX
@article{Zheng2025,
  author = {Zheng, Yangmin and Ma, Shubei and Sun, Wei and Yan, Feng and Luo, Yumin},
  title = {Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood–brain barrier integrity following rtPA reperfusion after MCAO in mice},
  journal = {Inflammopharmacology},
  year = {2025},
  doi = {10.1007/s10787-025-01757-3}
}
Kostenlos starten →